Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martina Zimmermann

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Cancer Research|September 23, 2010
Liver cancer protease activity profiles support therapeutic options with matrix metalloproteinase-activatable oncolytic measles virusMichael D Mühlebach, Thomas Schaser, Martina Zimmermann, et al.
Plos One|March 7, 2014
Attenuated and protease-profile modified sendai virus vectors as a new tool for virotherapy of solid tumorsMartina Zimmermann, Sorin Armeanu-Ebinger, Sascha Bossow, et al.
Journal of Neuro-Oncology|May 6, 2016
Intraventricular etoposide safety and toxicity profile in children and young adults with refractory or recurrent malignant brain tumorsKristian W Pajtler, Stephan Tippelt, Nele Siegler, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 25, 2021
Half-life extension of efficiently produced DARPin serum albumin fusions as a function of FcRn affinity and recyclingHannes Merten, Fabian Brandl, Martina Zimmermann, et al.
Gut|November 26, 2010
Dual antitumour effect of 5-azacytidine by inducing a breakdown of resistance-mediating factors and epigenetic modulationSascha Venturelli, Alexander Berger, Timo Weiland, et al.
Plos One|December 29, 2012
Selective protection of human liver tissue in TNF-targeting of cancers of the liver by transient depletion of adenosine triphosphateTimo Weiland, Kathrin Klein, Martina Zimmermann, et al.
International Journal of Oncology|April 11, 2009
Human precision-cut liver tumor slices as a tumor patient-individual predictive test system for oncolytic measles vaccine virusesMartina Zimmermann, Sorin Armeanu, Irina Smirnow, et al.
Plos One|September 11, 2013
Optical detection and virotherapy of live metastatic tumor cells in body fluids with vaccinia strainsHuiqiang Wang, Nanhai G Chen, Boris R Minev, et al.
Nature Communications|February 2, 2018
Adenoviral vector with shield and adapter increases tumor specificity and escapes liver and immune controlMarkus Schmid, Patrick Ernst, Annemarie Honegger, et al.
Plos One|July 23, 2011
Efficient colonization and therapy of human hepatocellular carcinoma (HCC) using the oncolytic vaccinia virus strain GLV-1h68Ivaylo Gentschev, Meike Müller, Marion Adelfinger, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Cancer Research|September 23, 2010
Liver cancer protease activity profiles support therapeutic options with matrix metalloproteinase-activatable oncolytic measles virusMichael D Mühlebach, Thomas Schaser, Martina Zimmermann, et al.
Plos One|March 7, 2014
Attenuated and protease-profile modified sendai virus vectors as a new tool for virotherapy of solid tumorsMartina Zimmermann, Sorin Armeanu-Ebinger, Sascha Bossow, et al.
Journal of Neuro-Oncology|May 6, 2016
Intraventricular etoposide safety and toxicity profile in children and young adults with refractory or recurrent malignant brain tumorsKristian W Pajtler, Stephan Tippelt, Nele Siegler, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 25, 2021
Half-life extension of efficiently produced DARPin serum albumin fusions as a function of FcRn affinity and recyclingHannes Merten, Fabian Brandl, Martina Zimmermann, et al.
Gut|November 26, 2010
Dual antitumour effect of 5-azacytidine by inducing a breakdown of resistance-mediating factors and epigenetic modulationSascha Venturelli, Alexander Berger, Timo Weiland, et al.
Plos One|December 29, 2012
Selective protection of human liver tissue in TNF-targeting of cancers of the liver by transient depletion of adenosine triphosphateTimo Weiland, Kathrin Klein, Martina Zimmermann, et al.
International Journal of Oncology|April 11, 2009
Human precision-cut liver tumor slices as a tumor patient-individual predictive test system for oncolytic measles vaccine virusesMartina Zimmermann, Sorin Armeanu, Irina Smirnow, et al.
Plos One|September 11, 2013
Optical detection and virotherapy of live metastatic tumor cells in body fluids with vaccinia strainsHuiqiang Wang, Nanhai G Chen, Boris R Minev, et al.
Nature Communications|February 2, 2018
Adenoviral vector with shield and adapter increases tumor specificity and escapes liver and immune controlMarkus Schmid, Patrick Ernst, Annemarie Honegger, et al.
Plos One|July 23, 2011
Efficient colonization and therapy of human hepatocellular carcinoma (HCC) using the oncolytic vaccinia virus strain GLV-1h68Ivaylo Gentschev, Meike Müller, Marion Adelfinger, et al.
Pageof 9